Safety of percutaneous cryoablation in patients with painful bone and soft tissue tumors: A single center prospective study (SCIRO-1502)

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)

Abstract

This single center prospective study is being conducted to evaluate the safety of the cryoablation for patients with pathologically diagnosed painful bone and soft tissue tumors. Enrollment of 10 patients is planned over the 3-year recruitment period. Patients have related local pain after receiving medications or external radiation therapies will be included in this study. Cryoablation will be percutaneously performed under imaging guidance, and a temperature sensor will be used during treatment as necessary. The primary endpoint is prevalence of severe adverse events within 4 weeks after therapy. The secondary endpoint is effectiveness 4 weeks after the procedure.

Original languageEnglish
Pages (from-to)303-306
Number of pages4
JournalActa medica Okayama
Volume70
Issue number4
Publication statusPublished - 2016

Keywords

  • Cryoablation
  • Pain
  • Safety
  • Soft tissue and bone tumor

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Fingerprint Dive into the research topics of 'Safety of percutaneous cryoablation in patients with painful bone and soft tissue tumors: A single center prospective study (SCIRO-1502)'. Together they form a unique fingerprint.

Cite this